ORBIMED ADVISORS LLC
10% Owner; Director; Director, 10% Owner · 14 filings · Latest: Jun 22, 2026
Adicet Bio, Inc.
Enliven Therapeutics, Inc.
ImageneBio, Inc.
Prelude Therapeutics Inc
Q32 Bio Inc.
Shattuck Labs, Inc.
Sionna Therapeutics, Inc.
Traws Pharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
IRON | OrbiMed Private Investments VIII, LP | — | Mar 10, 2025 | Proposed Sale | $55.67 | 299,200 | $16.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Jan 6, 2025 | Proposed Sale | $0.829 | 1,140,740 | $945.7K | — | |
PASG | OrbiMed Private Investments VII, LP | — | Dec 4, 2024 | Proposed Sale | $0.89 | 2,985,518 | $2.7M | — | |
PASG | OrbiMed Private Investments VII, LP | — | Sep 16, 2024 | Proposed Sale | $0.807 | 927,572 | $748.6K | — |
← Previous
Page 3 of 3